Literature DB >> 12727636

Gene expression dynamics during germinal center transit in B cells.

Ulf Klein1, Yuhai Tu, Gustavo A Stolovitzky, Jeffrey L Keller, Joseph Haddad, Vladan Miljkovic, Giorgio Cattoretti, Andrea Califano, Riccardo Dalla-Favera.   

Abstract

The germinal center (GC) reaction in T cell dependent antibody responses is crucial for the generation of B cell memory and plays a critical role in B cell lymphomagenesis. To gain insight into the physiology of this reaction, we identified the transcriptional changes that occur in B cells during the GC-transit (naïve B cells --> CD77(+) centroblasts (CBs) --> CD77(-) centrocytes (CCs) --> memory B cells) by DNA microarray experiments and the subsequent data analysis employing unsupervised and supervised hierarchical clustering. The naïve B cell is characterized by a nonproliferative, anti-apoptotic phenotype and the expression of various chemokine and cytokine receptors. The transition from naïve B cells to CBs is associated with (1) the up-regulation of genes associated with cellular proliferation, DNA-repair, and chromatin remodeling; (2) the acquisition of a pro-apoptotic phenotype; (3) the down-regulation of cytokine, chemokine, and adhesion receptors expressed in the naïve cells; and (4) the expression of a distinct adhesion repertoire. The CB and the CC revealed surprisingly few gene expression differences, suggesting that the CC is heterogeneous in its cellular composition. The CB/CC to memory B cell transition shows a general reversion to the profile characteristic for the naïve B cells, with the exception of the up-regulation of several surface receptors, including CD27, CD80, and IL-2Rbeta, and the simultaneous expression of both anti- and pro-apoptotic genes. These gene expression profiles of the normal B cell subpopulations are being used to identify the signals occurring during GC development, the cellular derivation of various types of B cell malignancies, and the genes deregulated in GC-derived tumors.

Entities:  

Mesh:

Year:  2003        PMID: 12727636     DOI: 10.1111/j.1749-6632.2003.tb06045.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  7 in total

Review 1.  Electrophysiological and gene expression profiling of neuronal cell types in mammalian neocortex.

Authors:  Kojiro Yano; Tatiana Subkhankulova; Frederick J Livesey; Hugh P C Robinson
Journal:  J Physiol       Date:  2006-07-13       Impact factor: 5.182

2.  MicroRNA 28 controls cell proliferation and is down-regulated in B-cell lymphomas.

Authors:  Christof Schneider; Manu Setty; Antony B Holmes; Roy L Maute; Christina S Leslie; Lara Mussolin; Angelo Rosolen; Riccardo Dalla-Favera; Katia Basso
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-19       Impact factor: 11.205

3.  Repression of the proapoptotic cellular BIK/NBK gene by Epstein-Barr virus antagonizes transforming growth factor β1-induced B-cell apoptosis.

Authors:  Eva M Campion; Roya Hakimjavadi; Sinéad T Loughran; Susan Phelan; Sinéad M Smith; Brendan N D'Souza; Rosemary J Tierney; Andrew I Bell; Paul A Cahill; Dermot Walls
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

Review 4.  BIK, the founding member of the BH3-only family proteins: mechanisms of cell death and role in cancer and pathogenic processes.

Authors:  G Chinnadurai; S Vijayalingam; R Rashmi
Journal:  Oncogene       Date:  2008-12       Impact factor: 9.867

5.  The hierarchical process of differentiation of long-lived antibody-secreting cells is dependent on integrated signals derived from antigen and IL-17A.

Authors:  Lidiane Zito Grund; Monica Lopes-Ferreira; Carla Lima
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

Review 6.  Remembrance of Things Past: Long-Term B Cell Memory After Infection and Vaccination.

Authors:  Anna-Karin E Palm; Carole Henry
Journal:  Front Immunol       Date:  2019-07-31       Impact factor: 7.561

Review 7.  Visualizing the Immune System: Providing Key Insights into HIV/SIV Infections.

Authors:  Jacob D Estes; Roger LeGrand; Constantinos Petrovas
Journal:  Front Immunol       Date:  2018-03-02       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.